Ken Griffin
ANIX icon

Ken Griffin’s Anixa Biosciences ANIX Stock Holding History

Ken Griffin’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-29,692
Closed -$87.9K – 12917
2025
Q4 		$92.6K Sell
29,692
-66,318
-69% -$272K ﹤0.01% 11700
2025
Q3 		$317K Buy
96,010
+25,072
+35% +$79.3K ﹤0.01% 10230
2025
Q2 		$234K Buy
+70,938
New +$203K ﹤0.01% 10358
2025
Q1 		– Sell
-87,919
Closed -$251K – 14410
2024
Q4 		$204K Buy
87,919
+82,234
+1,447% +$255K ﹤0.01% 10423
2024
Q3 		$17.9K Buy
+5,685
New +$17.5K ﹤0.01% 12864
2024
Q2 		– Sell
-38,254
Closed -$119K – 14176
2024
Q1 		$119K Buy
38,254
+21,559
+129% +$86K ﹤0.01% 11111
2023
Q4 		$64.8K Sell
16,695
-23,880
-59% -$80.5K ﹤0.01% 11492
2023
Q3 		$133K Sell
40,575
-2,117
-5% -$7.41K ﹤0.01% 10531
2023
Q2 		$137K Buy
42,692
+31,478
+281% +$121K ﹤0.01% 10463
2023
Q1 		$48.2K Sell
11,214
-36,292
-76% -$159K ﹤0.01% 12199
2022
Q4 		$202K Buy
47,506
+27,896
+142% +$134K ﹤0.01% 10119
2022
Q3 		$97K Sell
19,610
-4,684
-19% -$19K ﹤0.01% 11118
2022
Q2 		$74K Buy
+24,294
New +$76.6K ﹤0.01% 11655
2022
Q1 		– Sell
-33,935
Closed -$101K – 13501
2021
Q4 		$101K Buy
33,935
+19,677
+138% +$79.6K ﹤0.01% 12714
2021
Q3 		$68K Buy
+14,258
New +$64.3K ﹤0.01% 13174
2021
Q2 		– Sell
-19,682
Closed -$83.8K – 13607
2021
Q1 		$92K Buy
19,682
+5,184
+36% +$24.8K ﹤0.01% 12535
2020
Q4 		$45K Buy
+14,498
New +$36.4K ﹤0.01% 10598

Other funds holding ANIX

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ken Griffin's ANIX Position: Q1 2026 in Review

Ken Griffin sold out of Anixa Biosciences (ANIX) in Q1 2026, closing a stake of 29,692 shares — an estimated $87.9K sold.

Ken Griffin first reported a position in ANIX in Q4 2020 and held it in 17 quarters. The position peaked at $317K in Q3 2025. 60 funds tracked by Wall St. Rank hold ANIX as of Q1 2026.

  • Ken Griffin reported no remaining Anixa Biosciences position as of Q1 2026 after selling out during the quarter.
  • Ken Griffin sold 29,692 Anixa Biosciences shares in Q1 2026, an estimated $87.9K.
  • Ken Griffin first reported a position in Anixa Biosciences in Q4 2020 and held it in 17 quarters.
  • Ken Griffin's Anixa Biosciences position peaked at $317K in Q3 2025.
  • 60 funds tracked by Wall St. Rank held Anixa Biosciences as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.